Functional Prostacyclin Synthase Promoter Polymorphisms. Impact in Pulmonary Arterial Hypertension

Rationale: Pulmonary arterial hypertension (PAH) is a progressive disease characterized by elevated pulmonary artery pressure, vascular remodeling, and ultimately right ventricular heart failure. PAH can have a genetic component (heritable PAH), most often through mutations of bone morphogenetic pro...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Stearman, Robert S., Cornelius, Amber R., Lu, Xiao, Conklin, David S., Del Rosario, Mark J., Lowe, Anita M., Elos, Mihret T., Fettig, Lynsey M., Wong, Randall E., Hara, Naoko, Cogan, Joy D., Phillips, John A., Taylor, Matthew R., Graham, Brian B., Tuder, Rubin M., Loyd, James E., Geraci, Mark W.
Formato: Artigo
Idioma:Inglês
Publicado: American Thoracic Society 2014
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4098107/
https://ncbi.nlm.nih.gov/pubmed/24605778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201309-1697OC
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares